JSAM
PFE icon

J. Safra Asset Management’s Pfizer PFE Stock Holding History

J. Safra Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.3K Sell
220
-630
-74% -$16.5K ﹤0.01% 494
2026
Q1 		$23.9K Hold
850
– – ﹤0.01% 295
2025
Q4 		$21.2K Buy
+850
New +$21.4K ﹤0.01% 321
2016
Q4 		– Sell
-1,775
Closed -$57K – 106
2016
Q3 		$57K Sell
1,775
-769
-30% -$25.7K 0.1% 48
2016
Q2 		$85K Sell
2,544
-22,300
-90% -$712K 0.14% 69
2016
Q1 		$699K Sell
24,844
-5,858
-19% -$167K 0.57% 39
2015
Q4 		$940K Buy
+30,702
New +$966K 0.72% 30

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

J. Safra Asset Management's PFE Position: Q2 2026 in Review

J. Safra Asset Management reduced its Pfizer (PFE) stake by 74% in Q2 2026, selling an estimated $16.5K and leaving 220 shares worth $5.3K. The position accounts for ﹤0.01% of the portfolio, ranked #494.

J. Safra Asset Management first reported a position in PFE in Q4 2015 and has held it in 7 quarters since. The position peaked at $940K in Q4 2015. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • J. Safra Asset Management held 220 shares of Pfizer worth $5.3K as of Q2 2026.
  • J. Safra Asset Management sold 630 Pfizer shares in Q2 2026, an estimated $16.5K.
  • Pfizer made up ﹤0.01% of J. Safra Asset Management's portfolio in Q2 2026, its #494 holding.
  • J. Safra Asset Management first reported a position in Pfizer in Q4 2015 and has held it in 7 quarters since.
  • J. Safra Asset Management's Pfizer position peaked at $940K in Q4 2015.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.